KR100187333B1 - 클라불란산의 디아민염 - Google Patents
클라불란산의 디아민염 Download PDFInfo
- Publication number
- KR100187333B1 KR100187333B1 KR1019940704230A KR19940704230A KR100187333B1 KR 100187333 B1 KR100187333 B1 KR 100187333B1 KR 1019940704230 A KR1019940704230 A KR 1019940704230A KR 19940704230 A KR19940704230 A KR 19940704230A KR 100187333 B1 KR100187333 B1 KR 100187333B1
- Authority
- KR
- South Korea
- Prior art keywords
- clavulanic acid
- salt
- diamine
- pharmaceutically acceptable
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
- C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
- C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
- C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93200872.5 | 1993-03-26 | ||
| EP93200872 | 1993-03-26 | ||
| PCT/EP1994/000919 WO1994022873A1 (en) | 1993-03-26 | 1994-03-22 | Diamine salts of clavulanic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR950701635A KR950701635A (ko) | 1995-04-28 |
| KR100187333B1 true KR100187333B1 (ko) | 1999-05-01 |
Family
ID=8213723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940704230A KR100187333B1 (ko) | 1993-03-26 | 1994-03-22 | 클라불란산의 디아민염 |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JP2839955B2 (bg) |
| KR (1) | KR100187333B1 (bg) |
| BG (1) | BG61948B1 (bg) |
| BR (1) | BR9404743A (bg) |
| GR (2) | GR950300030T1 (bg) |
| LV (1) | LV11180B (bg) |
| RU (1) | RU2135502C1 (bg) |
| SI (1) | SI0647229T1 (bg) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1578739A (en) * | 1976-07-23 | 1980-11-05 | Beecham Group Ltd | Amine salts of clavulanic acid methods for their preparation and compositions containing them |
| AT399155B (de) * | 1992-03-26 | 1995-03-27 | Lek Tovarna Farmacevtskih | Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung |
-
1994
- 1994-03-22 RU RU94046014A patent/RU2135502C1/ru active
- 1994-03-22 JP JP6521641A patent/JP2839955B2/ja not_active Expired - Lifetime
- 1994-03-22 KR KR1019940704230A patent/KR100187333B1/ko not_active IP Right Cessation
- 1994-03-22 SI SI9430013T patent/SI0647229T1/xx unknown
- 1994-03-22 BR BR9404743-0A patent/BR9404743A/pt not_active Application Discontinuation
- 1994-11-22 LV LVP-94-220A patent/LV11180B/en unknown
- 1994-11-25 BG BG99212A patent/BG61948B1/bg unknown
-
1995
- 1995-06-30 GR GR950300030T patent/GR950300030T1/el unknown
-
1996
- 1996-10-16 GR GR960402720T patent/GR3021347T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9404743A (pt) | 1999-09-28 |
| RU2135502C1 (ru) | 1999-08-27 |
| GR950300030T1 (en) | 1995-06-30 |
| LV11180B (en) | 1996-08-20 |
| JPH07507573A (ja) | 1995-08-24 |
| LV11180A (lv) | 1996-04-20 |
| GR3021347T3 (en) | 1997-01-31 |
| RU94046014A (ru) | 1996-10-10 |
| KR950701635A (ko) | 1995-04-28 |
| JP2839955B2 (ja) | 1998-12-24 |
| BG99212A (bg) | 1995-12-29 |
| BG61948B1 (bg) | 1998-10-30 |
| SI0647229T1 (en) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU212583B (en) | New process for producing potassium salt of clavulanic acid | |
| AU655718B2 (en) | Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof | |
| EP0647229B1 (en) | Diamine salts of clavulanic acid | |
| IE56488B1 (en) | Crystalline cephem-acid addition salts and process for their preparation | |
| EP0594099B1 (en) | Process for the purification of crude clavulanic acid | |
| US7547777B2 (en) | Penam crystals and process for producing the same | |
| US5726170A (en) | Clavulanic acid salts | |
| US20020193587A1 (en) | Penicillin crystal and process for producing the same | |
| US20020193588A1 (en) | Crystals of penicillin and process for the production thereof | |
| KR100187333B1 (ko) | 클라불란산의 디아민염 | |
| AU702968B2 (en) | Clavulanic acid salts | |
| HU207087B (en) | Process for producing crystalline acid addition salts of cefemcarboxylic acid | |
| US5821364A (en) | Diamine salts of clavulanic acid | |
| SU1169541A3 (ru) | Способ получени йодметил 6-/ @ -2-азидо-2-фенилацетамидо/пеницилланоилоксиметил карбоната | |
| US5760218A (en) | Diamine salts of clavulanic acid | |
| DE3743111A1 (de) | Dierythromycin- und dicholinsalze von (3s(z))-2-(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)-amino)-2-oxoaethyliden)-amino)-oxy)-essigsaeure | |
| JP4616168B2 (ja) | （２ｓ，３ｓ）−３−［［（１ｓ）−１−イソブトキシメチル−３−メチルブチル］カルバモイル］オキシラン−２−カルボン酸の塩 | |
| EP0626967B1 (en) | Process for preparing enantiomerically pure fluorinated epoxychromans | |
| US5741903A (en) | Diamine salts for purification of clavulanic acid | |
| EP0007689A1 (en) | Production of sodium cephamandole derivatives | |
| US4394312A (en) | Process for preparing rifamycin derivatives | |
| US2969357A (en) | Penicillin salts of amino salicylates | |
| KR20020031391A (ko) | 베타-락탐 유도체의 합성방법 | |
| NO165024B (no) | L-vinsyre- o-monoestere av 3-morfolino-4-(3'-tert-butylamino-2'- hydroksypropoksy)-1,2,5 - tiadiazol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |